Sleep Deprivation: Clinical Issues, Pharmacology, and Sleep Loss EffectsClete A. Kushida Exploring the wide array of structures, substances, and environments that are primary factors in the initiation or inhibition of sleep, this reference highlights key findings from respected professionals around the globe on the social and economic burden of impaired performance, productivity, and safety arising from sleep deprivation-studying pharm |
Contents
| 1 | |
| 11 | |
3 Maintenance of Wakefulness Test | 25 |
Neurocognitive Assay Sensitive to Sleep Loss | 39 |
5 Major Sleep Disorders | 71 |
6 Medical Conditions and Diseases | 81 |
7 Neonates | 121 |
8 Inadequate Sleep in Children and Adolescents | 151 |
16 Military Operational Effectiveness | 289 |
17 Athletic Performance | 313 |
18 Medical ResidentPhysician Performance | 335 |
19 Legal Implications | 363 |
20 Stimulants | 387 |
21 Behavioral and Environmental Countermeasures | 447 |
22 Naps | 457 |
23 Sleep Restriction as Therapy for Insomnia | 475 |
9 Pregnancy and Postpartum | 177 |
10 Epidemiological Health Impact | 195 |
11 Societal and Economic Impact of Sleep Loss and Sleepiness | 211 |
12 General Occupational Implications of RoundtheClock Operations | 229 |
13 Impact on Selfreported Sleepiness Performance Effort and Motivation | 251 |
14 Driving Performance | 261 |
15 Commercial and Public Transportation Impact | 273 |
24 Recovery from Sleep Deprivation | 485 |
25 Sleep Length | 503 |
26 The Role of Endogenous Sleeppromoting Substances | 515 |
27 The Role of Pharmacological Interventions for Sleep Deprivation | 539 |
28 Eliminating Cumulative Sleep Debt and Sleep Satiation | 555 |
29 A Concluding Note on Sleep Deprivation and Sleep Mechanisms | 567 |
| 573 | |
Other editions - View all
Sleep Deprivation: Clinical Issues, Pharmacology, and Sleep Loss Effects Clete A. Kushida Limited preview - 2004 |
Sleep Deprivation: Clinical Issues, Pharmacology, and Sleep Loss Effects Clete A. Kushida No preview available - 2004 |
Common terms and phrases
accidents actigraphy activity adolescents adults alertness amphetamine assessment associated awake baseline behavior caffeine Carskadon chronic circadian circadian rhythm Clin clinical countermeasure daytime sleepiness decreased Dement WC depression dextroamphetamine Dinges DF dose driving drug edited effects of sleep Epworth Sleepiness Scale factors falling asleep fatigue formance function homeostatic hr of sleep impact impairment improved increased individuals insomnia levels measures methylphenidate modafinil mood MSLT naps narcolepsy neonatal RSD neurons Neurosci night nocturnal sleep NREM operations Parkinson's disease patients pemoline PGD2 Physiol physiological placebo pregnancy Psychol rats receptors recovery sleep reduced regulation REM sleep reported risk schedules shift short sleepers sleep debt sleep deprivation sleep disorders sleep disturbance sleep duration sleep inertia sleep latency sleep loss sleep onset Sleep Res sleep restriction sleep-wake slow-wave sleep stimulation subjects symptoms syndrome task tion total sleep deprivation treatment vigilance wakefulness